Shirayama_2019_Brain.Imaging.Behav_13_75

Reference

Title : rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine - Shirayama_2019_Brain.Imaging.Behav_13_75
Author(s) : Shirayama Y , Takahashi M , Oda Y , Yoshino K , Sato K , Okubo T , Iyo M
Ref : Brain Imaging Behav , 13 :75 , 2019
Abstract : Shirayama_2019_Brain.Imaging.Behav_13_75
ESTHER : Shirayama_2019_Brain.Imaging.Behav_13_75
PubMedSearch : Shirayama_2019_Brain.Imaging.Behav_13_75
PubMedID: 29247294

Related information

Citations formats

Shirayama Y, Takahashi M, Oda Y, Yoshino K, Sato K, Okubo T, Iyo M (2019)
rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine
Brain Imaging Behav 13 :75

Shirayama Y, Takahashi M, Oda Y, Yoshino K, Sato K, Okubo T, Iyo M (2019)
Brain Imaging Behav 13 :75